Real talk from the front lines of today’s research and manufacturing landscape
Read MoreNoel Maestre, PE, LEED AP
Vice President, Life Sciences
San Diego, CA

Noel Maestre is the Vice President of life sciences, focusing on strategy and evaluating market trends for CRB’s global life science practice. He has an extensive background in team leadership and engineering, specializing in facility planning through operation across traditional and advanced modalities.
Noel comes from an extensive background in mechanical and process utilities engineering with nearly 20 years of experience in the life science industry. He specializes in the design, construction and startup of biotechnology, pharmaceutical and advanced technology facilities, and has emerged as a cell and gene therapy SME. He is experienced in traditional biotechnology/pharmaceutical facility design, including a concentration on single-use process systems, batch versus continuous process and emerging technologies, such as cell and gene therapy. Noel is a graduate of Pennsylvania State University with a Bachelor of Science in mechanical engineering.
“I am extremely passionate about the life-saving promises of ATMP’s curative therapies and bringing them to market in record time.”
Insights By Noel

The dynamic future of life-saving medicine
Changing the way therapies work, and the changing work of making therapies.
Read More
Designing multimodal GMP suites
Considerations for dedicated and campaigned use
Read More
The future of cell and gene therapy
The future of cell and gene therapy and defending our global population from disease—those we know and those to come—requires new nimbleness for development and manufacturing.
Read More
Multimodal manufacturing—avoid challenges in the ATMP marketplace
Multimodal manufacturing facilities are designed to balance the efficiencies of a standardized and modular cleanroom template with just enough configurability to suit unique operator needs. As a result, they’re becoming known as a modern, cost-effective, highly flexible solution to the present-day challenges and future needs of ATMP manufacturing.
Read More